M
10b5-1 Plan
$ Value
$30K
Shares
1,652
Price
$18
Filed
Dec 4
Insider
Name
Hopper Jonathan Mark
Title
Chief Medical Officer
CIK
0001626325
Roles
Officer
Transaction Details
Transaction Date
2025-12-02
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
68,214
Footnotes
These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). | The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025. | These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.
Filing Info
Hopper Jonathan Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-02 | VCEL | M | $38K |
| 2026-04-02 | VCEL | ▼ | $122K |
| 2026-04-02 | VCEL | M | $0 |
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | $0 |
| 2026-02-24 | VCEL | F | $51K |
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | $0 |
| 2026-02-24 | VCEL | F | $24K |
| 2026-02-24 | VCEL | M | — |
Other Insiders at VCEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MCLAUGHLIN KEVIN F | — | $243K | 2026-02-11 |
|
Colangelo Dominick
President and CEO
|
— | — | 2026-02-24 |
| Rubino Alan L | — | — | 2026-03-25 |
| Hagen Heidi | — | $486K | 2026-03-23 |
|
Hopper Jonathan Mark
Chief Medical Officer
|
— | $122K | 2026-04-02 |
|
Halpin Michael
Chief Operating Officer
|
— | $364K | 2026-03-02 |
|
Flynn Sean C.
Chief Legal Officer
|
— | $754K | 2026-03-02 |
|
Mara Joseph Anthony Jr
Chief Financial Officer
|
— | — | 2026-02-24 |
|
SIEGAL JONATHAN
Principal Accounting Officer
|
— | — | 2026-02-24 |